These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3735088)

  • 61. Prediction of human percutaneous absorption from in vitro and in vivo animal experiments.
    Yoshimatsu H; Ishii K; Konno Y; Satsukawa M; Yamashita S
    Int J Pharm; 2017 Dec; 534(1-2):348-355. PubMed ID: 29111099
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The influence of water mixtures on the dermal absorption of glycol ethers.
    Traynor MJ; Wilkinson SC; Williams FM
    Toxicol Appl Pharmacol; 2007 Jan; 218(2):128-34. PubMed ID: 17173944
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Animal models for percutaneous absorption.
    Jung EC; Maibach HI
    J Appl Toxicol; 2015 Jan; 35(1):1-10. PubMed ID: 25345378
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evaluation of in-vivo animal and in-vitro models for prediction of dermal absorption in man.
    Jakasa I; Kezic S
    Hum Exp Toxicol; 2008 Apr; 27(4):281-8. PubMed ID: 18684798
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Structure-permeability relationship analysis of the permeation barrier properties of the stratum corneum and viable epidermis/dermis of rat skin.
    Yamaguchi K; Mitsui T; Aso Y; Sugibayashi K
    J Pharm Sci; 2008 Oct; 97(10):4391-403. PubMed ID: 18228598
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The in-vitro percutaneous absorption of glycerol trioleate through hairless mouse skin.
    Moloney SJ
    J Pharm Pharmacol; 1988 Nov; 40(11):819-21. PubMed ID: 2907569
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Tritiated Water Skin Barrier Integrity Test: Considerations for Acceptance Criteria with and Without
    Lehman PA; Beatch K; Raney SG; Franz TJ
    Pharm Res; 2017 Jan; 34(1):217-228. PubMed ID: 27822852
    [TBL] [Abstract][Full Text] [Related]  

  • 68. In vitro percutaneous absorption and metabolism of Bisphenol A (BPA) through fresh human skin.
    Toner F; Allan G; Dimond SS; Waechter JM; Beyer D
    Toxicol In Vitro; 2018 Mar; 47():147-155. PubMed ID: 29154941
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Maintenance of skin viability during in vitro percutaneous absorption/metabolism studies.
    Collier SW; Sheikh NM; Sakr A; Lichtin JL; Stewart RF; Bronaugh RL
    Toxicol Appl Pharmacol; 1989 Jul; 99(3):522-33. PubMed ID: 2749737
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Electrical resistance and tritiated water permeability as indicators of barrier integrity of in vitro human skin.
    Lawrence JN
    Toxicol In Vitro; 1997 Jun; 11(3):241-9. PubMed ID: 20654310
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Mechanism of percutaneous absorption. V. Percutaneous absorption of solvent deposited solids.
    Scheuplein RJ; Ross LW
    J Invest Dermatol; 1974 Apr; 62(4):353-60. PubMed ID: 4820679
    [No Abstract]   [Full Text] [Related]  

  • 72. The permeability of grafted human transplant skin in athymic mice.
    Scott RC; Rhodes C
    J Pharm Pharmacol; 1988 Feb; 40(2):128-9. PubMed ID: 2897445
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Percutaneous absorption of cortisone -4-C14 through normal human skin.
    MALKINSON FD; FERGUSON EH; WANG MC
    J Invest Dermatol; 1957 Mar; 28(3):211-6. PubMed ID: 13429160
    [No Abstract]   [Full Text] [Related]  

  • 74. Skin absorption: Flow-through or static diffusion cells.
    Clowes HM; Scott RC; Heylings JR
    Toxicol In Vitro; 1994 Aug; 8(4):827-30. PubMed ID: 20693022
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Bioengineered Skin Intended as In Vitro Model for Pharmacosmetics, Skin Disease Study and Environmental Skin Impact Analysis.
    Sanabria-de la Torre R; Fernández-González A; Quiñones-Vico MI; Montero-Vilchez T; Arias-Santiago S
    Biomedicines; 2020 Oct; 8(11):. PubMed ID: 33142704
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Estimating Maximal In Vitro Skin Permeation Flux from Studies Using Non-sink Receptor Phase Conditions.
    Yousef S; Liu X; Mostafa A; Mohammed Y; Grice JE; Anissimov YG; Sakran W; Roberts MS
    Pharm Res; 2016 Sep; 33(9):2180-94. PubMed ID: 27312087
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Design and Evaluation of a Novel Felbinac Transdermal Patch: Combining Ion-Pair and Chemical Enhancer Strategy.
    Liu N; Song W; Song T; Fang L
    AAPS PharmSciTech; 2016 Apr; 17(2):262-71. PubMed ID: 26070544
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Development and evaluation of curcumin-loaded elastic vesicles as an effective topical anti-inflammatory formulation.
    Agrawal R; Sandhu SK; Sharma I; Kaur IP
    AAPS PharmSciTech; 2015 Apr; 16(2):364-74. PubMed ID: 25319056
    [TBL] [Abstract][Full Text] [Related]  

  • 79. In vitro human skin permeation of endoxifen: potential for local transdermal therapy for primary prevention and carcinoma in situ of the breast.
    Lee O; Ivancic D; Chatterton RT; Rademaker AW; Khan SA
    Breast Cancer (Dove Med Press); 2011; 3():61-70. PubMed ID: 24367176
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The bioavailability of dermatological and other topically administered drugs.
    Guy RH; Guy AH; Maibach HI; Shah VP
    Pharm Res; 1986 Oct; 3(5):253-62. PubMed ID: 24271707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.